ClassID:

96898

C07K14/47 - page 4 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#901
20220064235
2022-03-03

Urine Markers and Methods for Detection of Bladder Cancer and Treatment Thereof

#902
20220064234
2022-03-03

Designed ankyrin repeat domains with altered surface residues

#903
20220064233
2022-03-03

Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens

#904
20220062387
2022-03-03

Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages

#905
20220062336
2022-03-03

Method for accelerating nerve regeneration

#906
20220062234
2022-03-03

Drug-controlled systems and uses thereof

#907
20220062145
2022-03-03

Peptides and compositions for use in cosmetics

#908
20220056139
2022-02-24

Lym-1 and Lym-2 antibody compositions and improved car constructs

#909
20220056103
2022-02-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#910
20220056088
2022-02-24

PEPTIDE DIRECTED PROTEIN KNOCKDOWN

#911
20220056087
2022-02-24

Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

#912
20220056086
2022-02-24

N-terminal capping modules of ankyrin repeat domains

#913
20220054506
2022-02-24

Immunoregulatory agent

#914
20220048961
2022-02-17

TRANSFERRIN RECEPTOR TARGETING PEPTIDES

#915
20220047697
2022-02-17

SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS

#916
20220047642
2022-02-17

AGENTS FOR PROMOTING TISSUE REGENERATION BY RECRUITING BONE MARROW MESENCHYMAL STEM CELLS AND/OR PLURIPOTENT STEM CELLS INTO BLOOD

#917
20220047501
2022-02-17

Method of treating osteoarthritis

#918
20220042063
2022-02-10

Peptide for enhancing expression efficiency of target protein, and fusion protein comprising same

#919
20220042023
2022-02-10

Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia

#920
20220041690
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

#921
20220041689
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

#922
20220041685
2022-02-10

ENGINEERED T-CELL MODULATING MOLECULES AND METHODS OF USING SAME

#923
20220040314
2022-02-10

Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist

#924
20220040236
2022-02-10

COMPOSITIONS AND METHODS OF TREATMENT OF VISION LOSS THROUGH GENERATION OF ROD PHOTORECEPTORS FROM MÜLLER GLIAL CELLS

#925
20220033469
2022-02-03

Peptides and combination of peptides for use in immunotherapy against various tumors

#926
20220033450
2022-02-03

VIRALLY EXPRESSED INHIBITORS OF PDZ DOMAINS, SUCH AS PICK1 AND USES THEREOF

#927
20220031850
2022-02-03

Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancer

#928
20220031834
2022-02-03

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#929
20220031778
2022-02-03

Method of reducing neuronal microtubule binding protein Tau (Tau) levels

#930
20220025000
2022-01-27

HETERODIMERIC PROTEINS FOR MODULATING GAMMA DELTA T CELLS

#931
20220024999
2022-01-27

METHODS OF MODULATING RNA

#932
20220023421
2022-01-27

METHODS FOR ELICITING SELECTIVE HUMORAL RESPONSES

#933
20220023383
2022-01-27

Pharmaceutical compositions and methods targeting Wnt pathway proteins

#934
20220017960
2022-01-20

INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF

#935
20220017885
2022-01-20

Repair of UV-induced DNA lesions

#936
20220017598
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

#937
20220017595
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

#938
20220017581
2022-01-20

Animal-free dietary collagen

#939
20220016206
2022-01-20

Isoform Nell-1 peptide

#940
20220016181
2022-01-20

IMMUNOMODULATORY CELLS AND USES THEREOF

#941
20220010347
2022-01-13

MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION

#942
20220009995
2022-01-13

Peptides and combination of peptides for use in immunotherapy against various tumors

#943
20220009991
2022-01-13

Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof

#944
20220009985
2022-01-13

Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases

#945
20220009977
2022-01-13

Methods of treating mitochondrial disorders

#946
20220009976
2022-01-13

Peptide Possessing Mesenchymal-Stem-Cell Mobilizing Activity

#947
20220008527
2022-01-13

Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof

#948
20220002419
2022-01-06

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

#949
20220002378
2022-01-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#950
20220002361
2022-01-06

Multimeric Hybrid Fc Proteins for Replacement of IVIG

#951
20220002360
2022-01-06

EXTRACELLULAR MATRIX PROTEIN COMPOSITIONS AND METHODS FOR TREATING WOUNDS

#952
20220002359
2022-01-06

Voltage-Gated Calcium Channel Auxilliary Subunit Alpha 2 Delta and Uses Thereof

#953
20220000972
2022-01-06

A METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER

#954
20210405034
2021-12-30

SYNTHETIC BI-EPITOPE COMPOUND

#955
20210403551
2021-12-30

Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody

#956
20210403530
2021-12-30

Peptides and combination of peptides for use in immunotherapy against various tumors

#957
20210403521
2021-12-30

Compositions and methods for diagnosing and/or treating kidney injury

#958
20210403518
2021-12-30

BISTABLE TYPE II OPSINS AND USES THEREOF

#959
20210403517
2021-12-30

D-domain containing polypeptides and uses thereof

#960
20210403516
2021-12-30

Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)

#961
20210403515
2021-12-30

Fusion-proteins based on human ferritin and protease-cleavable peptides and their use as chemotherapeutics carriers

#962
20210403513
2021-12-30

Budding yeast with human chromatin

#963
20210403507
2021-12-30

Peptide probe for recognition of G-quadruplex and use thereof in detection of G-quadruplex in cell

#964
20210401930
2021-12-30

Polypeptides binding to human complement C5

#965
20210401891
2021-12-30

D-domain containing polypeptides and uses thereof

#966
20210395778
2021-12-23

Codon optimized otoferlin AAV dual vector gene therapy

#967
20210395776
2021-12-23

Frataxin expression constructs having engineered promoters and methods of use thereof

#968
20210395736
2021-12-23

RASOPATHY TREATMENT

#969
20210395726
2021-12-23

SH3 domain derivatives

#970
20210395338
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#971
20210395337
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#972
20210395336
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#973
20210395335
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#974
20210395334
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#975
20210395319
2021-12-23

METHODS AND COMPOSITIONS COMPRISING TAU OLIGOMERS

#976
20210395318
2021-12-23

MULTISPECIFIC PROTEINS

#977
20210393755
2021-12-23

NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED TUMOUR ANTIGEN

#978
20210393687
2021-12-23

COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

#979
20210388119
2021-12-16

Circular tandem repeat proteins

#980
20210388042
2021-12-16

Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses

#981
20210388041
2021-12-16

Compositions and methods for treating or preventing fibrosis

#982
20210388040
2021-12-16

NON-CANONICAL SWI/SNF COMPLEX AND USES THEREOF

#983
20210386784
2021-12-16

CELLS AND METHODS FOR IMPROVED IMMUNOTHERAPY

#984
20210380686
2021-12-09

Inhibitors of T-cell activation

#985
20210380678
2021-12-09

TISSUE-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES

#986
20210380671
2021-12-09

COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY

#987
20210380651
2021-12-09

COMPOSITIONS FOR DISEASE TREATMENT

#988
20210380650
2021-12-09

USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD

#989
20210380649
2021-12-09

WNT/SFRP COMPLEXES, WNT-CONTAINING COMPOSITIONS, WNT-EXPRESSING CELLS, AND METHODS OF MAKING, PURIFYING, AND USING SAME

#990
20210380648
2021-12-09

DNA binding proteins and uses thereof

#991
20210379157
2021-12-09

Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders

#992
20210379147
2021-12-09

METHOD AND SYSTEM FOR TREATING CANCER UTILIZING TINAGL1

#993
20210373021
2021-12-02

SNAP-25 REPORTER CONSTRUCTS AND METHODS OF USING THE SAME

#994
20210372948
2021-12-02

VERSATILE DISPLAY SCAFFOLDS FOR PROTEINS

#995
20210371933
2021-12-02

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

#996
20210371867
2021-12-02

Alkaline phosphatase fusion antibody and method for producing the same, and immunoassay method

#997
20210371479
2021-12-02

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

#998
20210371478
2021-12-02

GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR

#999
20210369872
2021-12-02

HTT REPRESSORS AND USES THEREOF

#1000
20210363543
2021-11-25

Self Replicating RNA System

#1001
20210363534
2021-11-25

Compositions and methods for treating non-age-associated hearing impairment in a human subject

#1002
20210363257
2021-11-25

NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1

#1003
20210363204
2021-11-25

PROTOXIN-II VARIANTS AND METHODS OF USE

#1004
20210363203
2021-11-25

Modification and compositions of human secretoglobin proteins

#1005
20210363187
2021-11-25

Therapeutic peptides

#1006
20210355505
2021-11-18

SYNP78 (PROA27), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN RETINAL GANGLION CELLS

#1007
20210355179
2021-11-18

Methods and compositions for regenerating tissues

#1008
20210355177
2021-11-18

Molecules for organelle-specific protein delivery

#1009
20210353773
2021-11-18

SYNP194 (PROB15), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN RETINAL GANGLION CELLS

#1010
20210353728
2021-11-18

Peptides and combination of peptides for use in immunotherapy against various cancers

#1011
20210347913
2021-11-11

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

#1012
20210347866
2021-11-11

PEPTIDE IMMUNOGEN CONSTRUCTS DIRECTED AGAINST DIPEPTIDE REPEAT PROTEINS FROM C9ORF72

#1013
20210347835
2021-11-11

Ankyrin repeat binding proteins and their uses

#1014
20210347834
2021-11-11

Gene therapy vector for treating retinitis pigmentosa disease

#1015
20210346481
2021-11-11

Peptides and combination of peptides for use in immunotherapy against various cancers

#1016
20210340565
2021-11-04

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

#1017
20210340235
2021-11-04

Use of regulatory T cell-specific surface protein LRIG-1

#1018
20210340220
2021-11-04

VEGF antagonist formulations suitable for intravitreal administration

#1019
20210340198
2021-11-04

HMGB1 PROTEIN DERIVATIVES FOR THE REMOVAL OF BIOFILMS

#1020
20210340197
2021-11-04

DIRECTED PSEUDOURIDYLATION OF RNA

#1021
20210340196
2021-11-04

Granulysin, method of obtaining same, and uses

#1022
20210340195
2021-11-04

Miniaturized dystrophins having spectrin fusion domains and uses thereof

#1023
20210340114
2021-11-04

HETEROCYCLIC COMPOUND

#1024
20210332097
2021-10-28

Compositions for treatment of vascular disease

#1025
20210330870
2021-10-28

Compositions and materials for regeneration of skeletal muscle

#1026
20210330816
2021-10-28

GENE THERAPY FOR OCULAR DISORDERS

#1027
20210330814
2021-10-28

Methods of treating non-syndromic sensorineural hearing loss

#1028
20210324418
2021-10-21

RECOMBINANT VIRAL VECTORS AND NUCLEIC ACIDS FOR PRODUCING THE SAME

#1029
20210324360
2021-10-21

CYTOTOXIC MOLECULES RESPONSIVE TO INTRACELLULAR LIGANDS FOR SELECTIVE T CELL MEDIATED KILLING

#1030
20210322511
2021-10-21

METHODS AND COMPOSITIONS FOR TREATING A RESPIRATORY DISEASE

#1031
20210318329
2021-10-14

Sensors and assays for ubiquitin or ubiquitin-like proteins

#1032
20210317474
2021-10-14

Means and method for producing and purifying viral vectors

#1033
20210316013
2021-10-14

HAEMATOPOIETIC STEM CELL-GENE THERAPY FOR WISKOTT-ALDRICH SYNDROME

#1034
20210315814
2021-10-14

ARRDC1-MEDIATED MICROVESICLES (ARMMS) AND USES THEREOF

#1035
20210308206
2021-10-07

Activin type 2 receptor binding proteins methods of making them

#1036
20210308169
2021-10-07

METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

#1037
20210307304
2021-10-07

Non-human animals models of retinoschisis

#1038
20210302429
2021-09-30

Compositions and methods related to the methylation of histone H1.0 protein

#1039
20210301295
2021-09-30

Multiple rapid detection kits and methods for various viruses

#1040
20210301286
2021-09-30

TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES

#1041
20210301001
2021-09-30

ANTIBODY THAT BINDS MURINE WISE PROTEIN

#1042
20210300977
2021-09-30

CELL-PENETRATING PEPTIDE DIMERS, METHOD FOR PREPARING THE SAME, AND CARGO DELIVERY SYSTEM USING THE SAME

#1043
20210300976
2021-09-30

Fascin-2 (FSCN2) Variants And Uses Thereof

#1044
20210299278
2021-09-30

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

#1045
20210292792
2021-09-23

SYNP162, a promoter for the expression of genes

#1046
20210292785
2021-09-23

Importation of mitochondrial protein by an enhanced allotopic approach

#1047
20210292407
2021-09-23

CANCER TARGETS AND USES THEREOF

#1048
20210292383
2021-09-23

ALLERGY ANTIGEN AND EPITOPE THEREOF

#1049
20210290745
2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

#1050
20210290744
2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

#1051
20210284985
2021-09-16

PH20 polypeptide variants, formulations and uses thereof

#1052
20210284978
2021-09-16

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

#1053
20210284946
2021-09-16

Tumour immunogen, preparation method therefor, and application

#1054
20210284703
2021-09-16

Encryption device and operation method thereof

#1055
20210284692
2021-09-16

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

#1056
20210283242
2021-09-16

IMMUNE-MEDIATED CORONAVIRUS TREATMENTS

#1057
20210283231
2021-09-16

Peptides and combination of peptides for use in immunotherapy against various cancers

#1058
20210283230
2021-09-16

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1059
20210278407
2021-09-09

IDENTIFICATION, SELECTION AND USE OF HIGH CURATIVE POTENTIAL T CELL EPITOPES

#1060
20210277376
2021-09-09

PH20 polypeptide variants, formulations and uses thereof

#1061
20210277076
2021-09-09

Alpha-synuclein substrates and methods for making and using the same

#1062
20210277075
2021-09-09

Animal-free dietary collagen

#1063
20210277074
2021-09-09

Extended recombinant polypeptides and compositions comprising same

#1064
20210277073
2021-09-09

KIDNEY DISEASE TARGETS AND USES THEREOF

#1065
20210277052
2021-09-09

RECOMBINANT GRP94 CHAPERONES AND METHODS OF USING THE SAME TO MODULATE GLYCOSYLATION IN FUSION PROTEINS

#1066
20210275656
2021-09-09

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

#1067
20210275654
2021-09-09

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1068
20210275653
2021-09-09

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

#1069
20210269531
2021-09-02

Anti-TrkB agonist antibodies binding to D1 domain of TrkB

#1070
20210269504
2021-09-02

PROTEIN-BASED MICELLES FOR THE DELIVERY OF HYDROPHOBIC ACTIVE COMPOUNDS

#1071
20210268084
2021-09-02

Cancer vaccines and methods of treatment using the same

#1072
20210268081
2021-09-02

TARGETED EXPANSION OF QA-1-PEPTIDE-SPECIFIC REGULATORY CD8 T CELLS TO AMELIORATE ARTHRITIS

#1073
20210261647
2021-08-26

LAMP CONSTRUCTS COMPRISING ALLERGENS

#1074
20210261619
2021-08-26

Apelin polypeptides

#1075
20210260170
2021-08-26

Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system

#1076
20210253653
2021-08-19

Peptides for the treatment of resorptive bone disease

#1077
20210253651
2021-08-19

METHOD FOR PRODUCING ORGANIC COMPOUND-ENCAPSULATING FERRITIN

#1078
20210252119
2021-08-19

Regulatory T cell epitopes, compositions and uses thereof

#1079
20210238265
2021-08-05

Human Anti-Tau Antibodies

#1080
20210238249
2021-08-05

MODIFIED MITOCHONDRIA AND USE THEREOF

#1081
20210238237
2021-08-05

Method of managing joint pain

#1082
20210236609
2021-08-05

Regulatory T cell epitopes, compositions and uses thereof

#1083
20210236608
2021-08-05

Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same

#1084
20210236595
2021-08-05

Method of managing joint pain

#1085
20210236535
2021-08-05

MANIPULATION OF EIF3 TO MODULATE REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION

#1086
20210230577
2021-07-29

Cytosine to guanine base editor

#1087
20210230238
2021-07-29

Core domain of annexins and uses thereof in antigen delivery and vaccination

#1088
20210230237
2021-07-29

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION

#1089
20210230236
2021-07-29

Proteins for the treatment of epithelial barrier function disorders

#1090
20210228743
2021-07-29

Intrathecal delivery of recombinant adeno-associated virus 9

#1091
20210222134
2021-07-22

Biocatalysts for ezetimibe synthesis

#1092
20210221860
2021-07-22

Use of recombinant human secretory DDRGK1

#1093
20210220487
2021-07-22

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#1094
20210220485
2021-07-22

Expression cassette with a SynP160 promoter

#1095
20210214463
2021-07-15

Bi-specific fusion proteins

#1096
20210214408
2021-07-15

TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR

#1097
20210208164
2021-07-08

Method and means for diagnosing and treating allergy

#1098
20210206825
2021-07-08

EGFR and C-met fibronectin type III domain binding molecules

#1099
20210206824
2021-07-08

Fusion proteins comprising an engineered knottin peptide and uses thereof

#1100
20210206817
2021-07-08

Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor

#1101
20210206813
2021-07-08

Genetically encoded system for constructing and detecting biologically active agents

#1102
20210206810
2021-07-08

Detection of Optimal Recombinants Using Fluorescent Protein Fusions

#1103
20210198699
2021-07-01

KIT FOR REPARING FBN1T7498C MUTATION, COMBINATION FOR MAKING AND REPAIRING MUTATION, AND METHOD OF REPAIRING THEREOF

#1104
20210198692
2021-07-01

ADENO-ASSOCIATED VIRAL VECTOR-MEDIATED GENE THERAPY FOR TREATING FRAGILE X-ASSOCIATED DISORDERS

#1105
20210198629
2021-07-01

COMPOSITIONS AND METHODS FOR INCREASING BEIGING OF WHITE ADIPOSE TISSUE

#1106
20210198333
2021-07-01

EphA2 T-cell epitope agonists and uses therefore

#1107
20210198329
2021-07-01

Peptides for targeting LRP6-overexpressed cells

#1108
20210198328
2021-07-01

MODULATED CAS-INHIBITORS

#1109
20210198327
2021-07-01

SUMO AND USES THEREOF

#1110
20210196788
2021-07-01

TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA

#1111
20210189404
2021-06-24

METHOD FOR PRODUCING FUSION PROTEIN, NUCLEIC ACID, CELL, AND ANIMAL

#1112
20210188944
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#1113
20210188943
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#1114
20210188937
2021-06-24

LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST

#1115
20210188926
2021-06-24

METHODS AND COMPOSITIONS FOR GENOME ENGINEERING

#1116
20210188925
2021-06-24

PROGRANULIN VARIANTS

#1117
20210188901
2021-06-24

SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS

#1118
20210187069
2021-06-24

DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS

#1119
20210185990
2021-06-24

NON-MEIOTIC ALLELE INTROGRESSION

#1120
20210180135
2021-06-17

Biomarker pairs for predicting preterm birth

#1121
20210180082
2021-06-17

Programmable assembly of virus composites for receptor-targeted gene delivery

#1122
20210180024
2021-06-17

Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use

#1123
20210180015
2021-06-17

Membrane-Receiver Complex Therapeutics

#1124
20210179691
2021-06-17

Peptides and combination of peptides for use in immunotherapy against various tumors

#1125
20210179688
2021-06-17

Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies

#1126
20210179679
2021-06-17

SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE

#1127
20210179678
2021-06-17

Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer

#1128
20210177991
2021-06-17

Frataxin expression constructs

#1129
20210171926
2021-06-10

Modified cascade ribonucleoproteins and uses thereof

#1130
20210171590
2021-06-10

Method of treating inflammatory bowel disease

#1131
20210171589
2021-06-10

TRUNCATED CARTILAGE-HOMING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF

#1132
20210163899
2021-06-03

Fusion proteins for the detection of apoptosis

#1133
20210163585
2021-06-03

Antibodies specific for sulfation sites of Wnt pathway proteins

#1134
20210163561
2021-06-03

NBP158 and uses thereof

#1135
20210163551
2021-06-03

DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS

#1136
20210163550
2021-06-03

EXOSOME PACKAGING AND TARGETED AUTOPHAGY

#1137
20210162056
2021-06-03

Targeting macula densa cells as a new therapeutic approach for kidney disease

#1138
20210162005
2021-06-03

Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide

#1139
20210161971
2021-06-03

ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION

#1140
20210161817
2021-06-03

Therapeutic agents specifically delivered by exosomes for cancer treatment

#1141
20210161113
2021-06-03

NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE

#1142
20210155662
2021-05-27

MYC NUCLEIC ACIDS AND USES THEREOF

#1143
20210154329
2021-05-27

ANTI-TUMOR COMPOSITION COMPRISING GM-CSF GENE, Flt3L-TRAIL FUSION GENE, shRNA INHIBITING TGF-ß EXPRESSION, AND shRNA INHIBITING HSP EXPRESSION

#1144
20210154310
2021-05-27

Peptide conjugates

#1145
20210154232
2021-05-27

Manipulating ARID5B expression in immune cells to promote metabolism, survival, and function

#1146
20210147873
2021-05-20

TRIPLE FUNCTION ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF C9ORF72 ASSOCIATED DISEASES

#1147
20210147872
2021-05-20

ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF PROGRANULIN ASSOCIATED NEURODEGENERATIVE DISEASES OR DISORDERS

#1148
20210147870
2021-05-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF STARGARDT DISEASE

#1149
20210147556
2021-05-20

Methods of inhibiting integrin α9β1 activity

#1150
20210147501
2021-05-20

Peptides for angiogenic therapy

#1151
20210147496
2021-05-20

Peptides, hydrogel compositions and methods of use thereof

#1152
20210147495
2021-05-20

ICAM-1 targeted fusion enzymes

#1153
20210145936
2021-05-20

PEPTIDES DERIVED FROM ACTIN-LIKE PROTEIN 8 (ACTL8)

#1154
20210145700
2021-05-20

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF

#1155
20210139940
2021-05-13

Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates

#1156
20210139549
2021-05-13

COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF

#1157
20210139548
2021-05-13

NPY2 RECEPTOR AGONISTS

#1158
20210139547
2021-05-13

Optogenetic induction of neurodegenerative disease pathologies

#1159
20210138033
2021-05-13

NNIF and nNIF-related peptides and related methods

#1160
20210137811
2021-05-13

TRPV3 agonists for the treatment of skin conditions

#1161
20210130424
2021-05-06

Dual IL-2R and IL-7R binding compounds

#1162
20210130423
2021-05-06

COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING A FRAGMENT OF HUMAN HEAT SHOCK PROTEIN 90A AS AN ACTIVE INGREDIENT

#1163
20210130422
2021-05-06

Fusion protein, and pharmaceutical composition for preventing or treating cancer, containing same

#1164
20210130421
2021-05-06

DUAL-AAV VECTOR-BASED SYSTEMS AND METHODS FOR DELIVERING OVERSIZED GENES TO MAMMALIAN CELLS

#1165
20210130420
2021-05-06

RECOMBINANT BINDING PROTEINS TARGETING HER2 AND SERUM ALBUMIN, AND THEIR USES

#1166
20210130404
2021-05-06

PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME

#1167
20210128719
2021-05-06

MODULAR ANTIGEN TRANSPORTATION MOLECULES AND USES THEREOF IN ANIMALS

#1168
20210128681
2021-05-06

Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein

#1169
20210128671
2021-05-06

Adiponectin peptidomimetics for treating ocular disorders

#1170
20210123036
2021-04-29

Peptides and conjugates

#1171
20210122805
2021-04-29

Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS

#1172
20210122793
2021-04-29

De novo designed non-local beta sheet proteins

#1173
20210115474
2021-04-22

Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C

#1174
20210115120
2021-04-22

Methods and compositions for targeting polyubiquitin

#1175
20210115104
2021-04-22

AMYLIN ANALOGUES

#1176
20210115101
2021-04-22

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#1177
20210113655
2021-04-22

Polypeptide-polymer conjugates and methods of use thereof

#1178
20210108208
2021-04-15

TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT

#1179
20210106651
2021-04-15

BIO-MIMETIC FORMULATION

#1180
20210102956
2021-04-08

Engineered hERG channel proteins, vesicles and methods of identifying small molecule pharmacological agents

#1181
20210102938
2021-04-08

Methods for measuring small molecule affinity to cereblon

#1182
20210101971
2021-04-08

Methods for treatment of cancer comprising TIGIT-binding agents

#1183
20210100918
2021-04-08

Intrathecal Delivery of Recombinant Adeno-Associated Virus 9

#1184
20210100889
2021-04-08

Preparation of flagellin vaccine adjuvant-based vaccine to induce production of antibody recognizing conformation of antigens, and application thereof

#1185
20210093670
2021-04-01

MATERIALS AND METHODS FOR THE TREATMENT OF LEWY BODY DISORDERS

#1186
20210087238
2021-03-25

CELL PENETRATING PEPTIDES AND RELATED COMPOSITIONS AND METHODS

#1187
20210077634
2021-03-18

IN VIVO PRODUCTION OF PROTEINS

#1188
20210077464
2021-03-18

Anti-fungal inhibitors

#1189
20210071260
2021-03-11

TREATMENT TARGETING ONCOLOGY AND NEURODEGENERATION

#1190
20210070819
2021-03-11

ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#1191
20210069293
2021-03-11

MODIFIED BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION

#1192
20210069249
2021-03-11

METHODS AND COMPOSITIONS OF CYTOTOXIC T CELL DEPLETION

#1193
20210068377
2021-03-11

Rodents having a humanized TMPRSS gene

#1194
20210062219
2021-03-04

SMARTBAC BACULOVIRUS EXPRESSION SYSTEM AND APPLICATION THEREOF

#1195
20210062196
2021-03-04

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#1196
20210061869
2021-03-04

ATF5 peptide variants and uses thereof

#1197
20210061867
2021-03-04

Targeted intracellular delivery of large nucleic acids

#1198
20210061857
2021-03-04

PEPTIDES FROM PIWIL1

#1199
20210060179
2021-03-04

MODULATION OF LIVER GENES

#1200
20210060129
2021-03-04

IgG4 Fc fragment comprising modified hinge region